Navigation Links
Medco Announces Webcast for Annual Meeting of Shareholders
Date:5/10/2010

FRANKLIN LAKES, N.J., May 10 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. (NYSE: MHS) will webcast its Annual Meeting of Shareholders, which is being held on Wednesday, May 12, 2010.  The presentations by David B. Snow Jr., chairman and CEO, and his management team, will begin at 9 a.m. ET.

To access the live audio webcast, visit the Investor Relations section at www.medco.com/investor. The webcast will be available for replay for one year following the presentation.

About Medco

Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter™ for approximately 65 million members.

With more than 20,000 employees dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2009 revenues of nearly $60 billion, Medco ranks 35th on the Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies.

For more information, go to

SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Medco to Present at Upcoming Investor Conferences
2. Medco to Present at the Deutsche Bank 35th Annual Health Care Conference
3. Medco, Mayo Clinic Study Reveals Using a Simple Genetic Test Reduces Hospitalization Rates by Nearly a Third for Patients on Widely Prescribed Blood Thinner
4. NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
5. Medco to Advance Cancer Care with Personalized and Specialized Treatment for Oncology Patients
6. Medco to Present at Upcoming Investor Conferences
7. Medco Partners with AmeriCares to Rush Donated Medicines to Help Victims of the Haiti Earthquake
8. Medco, State of Illinois and Community Retail Pharmacies Launch Wired Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs
9. Medco Reforming Healthcare with Smarter Medicine; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost
10. Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75
11. Medco to Present at November 2009 Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014 STAAR Surgical Company (NASDAQ: ... of implantable lenses and delivery systems for the eye ... 4, 2014 of $20.0 million, a 10% increase over ... On a constant currency basis, revenues grew 11% during ... quarter of 2013.  The effect of foreign currency exchange ...
(Date:7/31/2014)... -- ResMed Inc. (NYSE: RMD ) today announced results ... June 30, 2014.  Revenue for the quarter was $415.2 million, ... 1 percent decrease on a constant currency basis). Net income ... the quarter ended June 30, 2013. Diluted earnings per share ... compared to the quarter ended June 30, 2013.  ...
(Date:7/31/2014)... Xencor Inc. (NASDAQ: XNCR ), a ... the treatment of autoimmune diseases, asthma and allergic ... the second quarter ended June 30, 2014 and provided ... "In the second quarter, we presented preclinical data ... (ATS) demonstrating three novel mechanisms of action of ...
Breaking Medicine Technology:STAAR Surgical Reports 10% Second Quarter Revenue Growth 2STAAR Surgical Reports 10% Second Quarter Revenue Growth 3STAAR Surgical Reports 10% Second Quarter Revenue Growth 4STAAR Surgical Reports 10% Second Quarter Revenue Growth 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 6STAAR Surgical Reports 10% Second Quarter Revenue Growth 7STAAR Surgical Reports 10% Second Quarter Revenue Growth 8STAAR Surgical Reports 10% Second Quarter Revenue Growth 9STAAR Surgical Reports 10% Second Quarter Revenue Growth 10STAAR Surgical Reports 10% Second Quarter Revenue Growth 11STAAR Surgical Reports 10% Second Quarter Revenue Growth 12STAAR Surgical Reports 10% Second Quarter Revenue Growth 13STAAR Surgical Reports 10% Second Quarter Revenue Growth 14STAAR Surgical Reports 10% Second Quarter Revenue Growth 15STAAR Surgical Reports 10% Second Quarter Revenue Growth 16STAAR Surgical Reports 10% Second Quarter Revenue Growth 17STAAR Surgical Reports 10% Second Quarter Revenue Growth 18STAAR Surgical Reports 10% Second Quarter Revenue Growth 19STAAR Surgical Reports 10% Second Quarter Revenue Growth 20STAAR Surgical Reports 10% Second Quarter Revenue Growth 21STAAR Surgical Reports 10% Second Quarter Revenue Growth 22STAAR Surgical Reports 10% Second Quarter Revenue Growth 23STAAR Surgical Reports 10% Second Quarter Revenue Growth 24STAAR Surgical Reports 10% Second Quarter Revenue Growth 25STAAR Surgical Reports 10% Second Quarter Revenue Growth 26STAAR Surgical Reports 10% Second Quarter Revenue Growth 27STAAR Surgical Reports 10% Second Quarter Revenue Growth 28STAAR Surgical Reports 10% Second Quarter Revenue Growth 29STAAR Surgical Reports 10% Second Quarter Revenue Growth 30STAAR Surgical Reports 10% Second Quarter Revenue Growth 31RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 2RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 3RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 4RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 5RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 6
(Date:8/1/2014)... The Judicial Panel on Multidistrict Litigation ... therapy caused strokes, heart attacks, and other injuries in ... F. Kennelly as the transferee judge and ordered what ... federal court. , As one of his first organizing ... of attorneys who will move the litigation forward on ...
(Date:8/1/2014)... plays a central role in regulating appetite and whole-body ... the brain,s control of food intake and body weight, ... has been unclear. A new study in ... PPARγ activity in a type of neuron known as ... to high-fat diet. Sabrina Diano and colleagues at ...
(Date:8/1/2014)... York, New York (PRWEB) August 01, 2014 ... filed in the wake of the 2012 Rejuvenate ... to move forward in New Jersey’s Bergen County ... documents filed in the proceeding, the Court has ... of Confidentiality governing any and all hard copy ...
(Date:8/1/2014)... first-of-its-kind study, researchers at University Hospitals Rainbow Babies & ... be at greater risk for death on a commercial ... flights worldwide between January 2010 and June 2013 and ... the age of 2. , The study was ... event of an in-flight pediatric fatality onboard commercial airline ...
(Date:8/1/2014)... 01, 2014 The evolving healthcare ... community pharmacies. At ThoughtSpot 2014, AmerisourceBergen and Good ... practices and resources to enhance patient care and ... on critical issues to give independent pharmacists the ... , ThoughtSpot show attendance experienced a nearly ...
Breaking Medicine News(10 mins):Health News:Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL 2Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 2Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 3Health News:New research characterizes in-flight pediatric deaths 2Health News:ThoughtSpot 2014 Inspires as General Session Concludes 2Health News:ThoughtSpot 2014 Inspires as General Session Concludes 3Health News:ThoughtSpot 2014 Inspires as General Session Concludes 4Health News:ThoughtSpot 2014 Inspires as General Session Concludes 5
... traffic pollution may increase respiratory problems and reduce lung ... studied the effects of road and traffic density on ... town of Ciudad Juarez in Mexico. , Our results ... at home or at school, can lead to chronic ...
... 13 The owners of five,separate Miami-based health ... Assistant Attorney General Alice S. Fisher of the ... the Southern District of,Florida announced today. Collectively, the ... $28.6 million worth of unnecessary durable,medical equipment (DME) ...
... Inc. (Nasdaq: ISIS ) announced today that ... orphan drug status to ISIS 333611 for,the treatment ... (ALS),commonly referred to as Lou Gehrig,s disease. ALS ... of muscle control that can,lead to death. ISIS ...
... part of NDA submission in 2009, SYDNEY, Australia, ... of a second Phase III clinical trial for its,lead ... placebo controlled, double blind safety extension trial is,designed to ... the,Company,s submission of a New Drug Application (NDA) to ...
... 13 This year, pack nutrients,into your holiday ... sponsored by Dairy Council of California.,Instead of ... serve lightened-up holiday classics like Candy Cane Cocoa, ... and the bone-building benefits,of calcium, a much-needed nutrient ...
... Mass. and NEW YORK, Dec. 13 Boston,Scientific ... Partners, a leading,private equity firm, today jointly announced ... will acquire from Boston Scientific its Fluid,Management and ... The,transaction is expected to close in the first ...
Cached Medicine News:Health News:Heavy traffic makes breathing a burden in children 2Health News:Medicare Fraud Strike Force Cases Result in Long Prison Terms for Five Health Care Company Owners 2Health News:Medicare Fraud Strike Force Cases Result in Long Prison Terms for Five Health Care Company Owners 3Health News:Medicare Fraud Strike Force Cases Result in Long Prison Terms for Five Health Care Company Owners 4Health News:Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS 2Health News:Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS 3Health News:QRxPharma Initiates Second Phase III Clinical Trial for its 'Dual Opioid' Pain Therapy 2Health News:Seasonal Sippers Supply Bone-Building Benefits 2Health News:Seasonal Sippers Supply Bone-Building Benefits 3Health News:Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million 2Health News:Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million 3Health News:Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million 4Health News:Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million 5
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTT/1P chairs are recommended for the ... room, static control, health care and ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTT/1P chairs are recommended for the ... room, static control, health care and ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... the BE Series for top performance ... industry, education, laboratory, clean room, static ...
... with concave seats and large backrests ... like seats, backrests, armrests, and casters ... Series for top performance in a ... laboratory, clean room, static control, health ...
Medicine Products: